On June 12, 2024, Sinboda Technology (Zhejiang) Co., Ltd. held a grand relocation ceremony at Building 1, No. 120, Qiuhe Road, Wutong Street, Tongxiang, Jiaxing, Zhejiang, marking a new phase of development for the company. This relocation not only reflects Sinboda Technology's firm commitment to continued investment in life and health technology platforms, but also underscores its ambitious vision of leading the future of health through innovation.
At the ceremony, the company's founders and core team gathered together to cut the ribbon at the new site, ushering in a new chapter in the company's development. In her address, CEO Dr. Xiaohua Chen fondly reviewed the company's journey since its establishment in August 2023, highly commended the team's efforts and contributions, and expressed boundless optimism and anticipation for the company's future. She emphasized that the inauguration of the new facility will provide a more advanced R&D environment and production conditions, enabling the company to further drive breakthroughs and applications in life and health technologies.
Following the ceremony, Sinboda Technology organized a series of diverse team-building activities to enhance team cohesion and boost employee morale. Employees actively participated, filling the venue with laughter and joy, showcasing the vibrant and positive spirit of the Sinboda Technology team. Additionally, the company thoughtfully prepared small gifts and afternoon tea for employees, allowing everyone to celebrate this important milestone in a relaxed and pleasant atmosphere.
Since its inception, Sinboda Technology has been dedicated to developing globally leading life and health technology platforms. Led by a team of Cambridge Ph.Ds and Zhejiang University PIs, the company brings together top-tier talent from both domestic and international arenas, spanning multidisciplinary fields such as artificial intelligence, optics, mechanics, electronics, and biochemistry. Currently, the company is fully advancing the R&D of innovative technologies including the 3D Real-time Fluorescence Microscopy Imaging Platform, the Single-Molecule Conformation Immunoassay Platform, the Single-Cell Micro-Nano Manipulation Platform, and the Digital Therapeutics Technology Platform, aiming to provide more advanced instruments and solutions for the medical and research sectors.
Looking ahead, Sinboda Technology will continue to uphold its mission of “Safeguarding lives, improving health, driving technological innovation, and leading the future.” Leveraging the superior conditions of its new premises, the company will further increase R&D investment and accelerate the pace of technological innovation, contributing greater wisdom and strength to the global life and health industry. At the same time, the company will actively expand domestic and international markets, join hands with more partners, and collectively open a new chapter in life and health technologies.
This relocation ceremony is not only an important milestone in Sinboda Technology's development journey, but also a vivid testament to the confidence and vision that all employees hold for the future. We firmly believe that with the collective efforts of every team member, Sinboda Technology will continue to go from strength to strength, becoming a shining star in the field of life and health technologies.
